Aim To report novel spectral domain optical coherence tomography (SD-OCT) findings and new mutational data in patients with ‘cone dystrophy with supernormal rod electroretinogram’, a recessive childhood onset retinal dystrophy consequent upon mutation in the KCNV2 gene.
Design/methods This was a comparative case series study of 12 patients with clinical and/or electrophysiological findings in keeping with KCNV2 mutation. Clinical examination and electrophysiological testing results were reviewed. Fundus photography and autofluorescence imaging were performed. Retinal layer appearance and thickness were evaluated using SD-OCT. The coding region and intron–exon boundaries of KCNV2 were screened by direct sequencing.
Results Mutations in KCNV2 were detected in all families; five of these changes were novel. Pattern electroretinograms were undetectable and full-field electroretinograms showed findings specific for the disorder. SD-OCT demonstrated bilateral morphological changes, usually confined to the fovea. Four foveal SD-OCT phenotypes were observed: (i) discontinuous inner and outer segment (IS/OS) junction reflectivity (6 patients), (ii) loss of IS/OS line and an optical gap in the foveola (2 patients); (iii) IS/OS junction disruption and profound foveal depth reduction, without optical gap and with preserved retinal pigment epithelium (RPE) complex (2 patients); and (iv) outer retina and RPE complex abnormalities (2 patients). Thinning of the neurosensory retina was observed in all eyes.
Conclusion In KCNV2 retinopathy foveal morphological changes are evident on SD-OCT even in the early stages of disease. However, there appears to be a window of opportunity, before marked structural damage has occurred, during which novel therapeutic intervention, such as gene replacement therapy, may rescue retinal function.
- cone dystrophy with supernormal rod ERG
Statistics from Altmetric.com
Voltage-gated potassium channels (Kv) are transmembrane proteins that control the excitability of electrically active cells and play a fundamental role in all organs and tissues. The human genome contains 40 Kvs, which are involved in diverse physiological processes.1 Each channel is formed by four α-subunits, each containing six transmembrane regions clustering around a central pore. KCNV2 encodes Kv8.2, a 545-amino acid Kv subunit highly expressed in the inner segments of rod and cone photoreceptors of the human retina and known to form heteromeric channels with Kv2.1 subunits.2 3
Recessive mutations in KCNV2 have been shown to cause a specific retinal dystrophy, ‘cone dystrophy with supernormal rod electroretinogram (ERG)’, which is the first disorder of the visual system to be associated with a potassium channel defect in man.3 This condition was initially described in 1983 as a progressive degeneration of the cone photoreceptors associated with unique rod system abnormalities.4 Patients typically present in the first 2 decades of life with reduced visual acuity, disturbance of colour vision and photophobia. Nyctalopia may also be a feature of the disorder. Affected individuals are often myopic, have a normal peripheral retinal appearance and a range of macular abnormalities on funduscopy and autofluorescence imaging.5 Early diagnosis is enabled by specific electrophysiological findings. Light-adapted ERGs are usually delayed and subnormal in keeping with generalised cone system dysfunction. There is a unique rod system abnormality: dark-adapted responses to dim flashes are very delayed and subnormal but with increasing flash intensity there is disproportionate enlargement of the ERG b-wave amplitude accompanied by shortening of b-wave peak time.5 6 This combination of findings has not been reported in association with any other disorder.
The detailed structural changes associated with KCNV2 mutation have not been previously reported. The present study describes spectral domain optical coherence tomography (SD-OCT) findings in 12 patients with KCNV2 retinopathy and reports five novel mutations.
Twelve subjects (eight simplex cases and two sibling pairs) with clinical and/or electrophysiological examination suggestive of ‘cone dystrophy with supernormal rod ERG’ were ascertained in the Inherited Eye Disease Service and Electrophysiology Department of Moorfields Eye Hospital, London, UK. Eight of these cases have been partially described in earlier reports, which did not include OCT imaging or the novel mutations described herein.3 6 Following informed consent, blood samples from affected individuals were collected for DNA extraction and subsequent mutation screening of KCNV2. The proband of one family (case 2) declined to donate blood for analysis and screening was performed with consent on parental DNA; there was consent to take part in all other aspects of the study. The study was approved by the local research ethics committee and all investigations were conducted in accordance with the principles of the Declaration of Helsinki.
Clinical evaluation and SD-OCT
Clinical assessment included detailed history, best corrected Snellen and/or logMAR visual acuity, dilated fundus examination, colour fundus photography, autofluorescence imaging with a confocal scanning laser ophthalmoscope and SD-OCT.
The Spectralis HRA+OCT with viewing module version 18.104.22.168 (Heidelberg Engineering, Heidelberg, Germany; 3.9 μm axial resolution) was used to acquire tomographs. Our protocol included a horizontal, centred on the fovea, linear scan and a volume scan (19 B-scans, 20°×15°) for each eye. When subjects were unable to comply, the number of frames per B-scan was adjusted.
SD-OCT data were analysed qualitatively, with comparisons made between patients and degree of inter-ocular symmetry investigated. Central point and retinal thickness in the Early Treatment Diabetic Retinopathy Study (ETDRS) central subfield were assessed. HEYEX software interface (v 22.214.171.124; Heidelberg Engineering) was used for all measurements. Identification and evaluation of the true dimensions of the outer nuclear layer would be a better indicator of photoreceptor loss compared to global thickness, but the technique used to acquire images was not optimal for accurate segmentation and appropriate normative data are lacking.7
All subjects underwent electrophysiological assessment that included full-field ERGs and pattern ERG testing that incorporated the minimum standards of the International Society for Clinical Electrophysiology of Vision (ISCEV). The protocol also included the recording of dark-adapted ERGs to an intensity series of flashes ranging from 0.001 cd.s.m−2 to 11.5 cd.s.m−2 in eight increments.
Genomic DNA was extracted from the peripheral blood lymphocytes of the donated blood samples. The KCNV2 coding region and intron–exon boundaries of exons 1 and 2 (NM_133497.2) were amplified and sequenced according to previously described methods.3 The novel p.Thr439Ile variant was tested with 50 ethnically matched control DNAs, while the p.Ala322Pro variant was tested in 95 randomly selected, unrelated UK Caucasian blood donor DNAs (ECACC, HRC-2, Health Protection Agency Culture Collections, Salisbury, UK).
Clinical and SD-OCT findings
The clinical findings are summarised in table 1. Patients were between 13 and 48 years old and presented with reduced central vision and/or photophobia which had commenced in the first or second decade of life. Visual acuity ranged from 0.20 to 1.30 logMAR (mean 0.71). Patients 2, 5 and 8 as well as the sibling pair of 6 and 7 were born to consanguineous parents.
Pattern ERGs were undetectable in all 11 patients tested, indicating severe macular dysfunction. Full-field ERGs showed the characteristic combination of findings previously described as pathognomonic for ‘cone dystrophy with supernormal rod ERG’5 6 in all 12 patients. ERGs from patients 8 and 12 are compared with normal traces in figure 1.
Fundus autofluorescence imaging revealed abnormal macular autofluorescence in all patients. The pattern of abnormality was variable and ranged from a small perifoveal ring of increased signal (eg, case 1) to a central area of absent autofluorescence corresponding to retinal pigment epithelium (RPE) atrophy (eg, case 12) (figure 2).
SD-OCT demonstrated structural changes in all 23 eyes tested (one eye was not included in the analysis due to unstable fixation). The findings were concordant between eyes in all patients. Discontinuous reflectivity of the hyper-reflective band corresponding to the photoreceptor inner and outer segment (IS/OS) junction was the predominant feature in 11 eyes (cases 1, 3, 4, 5, 8 and 9). In four eyes (cases 6 and 7), disruption was more profound and an optical gap was seen (elsewhere described as a hyporeflective zone).8 The thin reflective line corresponding to the external limiting membrane was relatively preserved in both groups. Extensive loss of IS/OS junction reflectivity with significant foveal depth reduction and a preserved RPE/Bruch's membrane complex was seen in four eyes (cases 2 and 11). RPE/Bruch's membrane band thinning was observed in addition to the photoreceptor loss in four eyes (cases 10 and 12). Mean central point thickness (CPT) was 141.26 μm (n=23) and mean ETDRS central subfield thickness (CSF) was 204.84 μm (n=19). Both CPT and CSF were significantly reduced compared to normative data (CPT: 227.3±23.2 μm, CSF: 270.2±22.5 μm), although part of this difference may be due to age, sex and axial length variability.9 Peripheral outer retinal architecture was relatively well preserved on the basis of the 20°×15° OCT volume scans (n=19 eyes).
In terms of age, two groups can be highlighted in the present cohort. OCTs in the first group (cases 3–7, aged 16–20) demonstrated relative preservation of the external limiting membrane and focal loss of photoreceptor outer segments. A more severe phenotype was observed in the second group (cases 9–12, aged 43–48), where there was more marked photoreceptor and/or RPE loss in three out of four patients (figure 2).
Genetic analysis results
Either homozygous or compound heterozygous mutations were detected in nine families. Only a single heterozygous variant could be detected in one family (case 1). Five novel mutations were identified, including two missense variants: one (p.Ala322Pro) altering a not particularly conserved amino acid, located in the second transmembrane helix, and one (p.Thr439Ile) occurring at a site that is fully conserved across vertebrates and highly conserved in other Kvs, located in close proximity to the pore region (amino acids 446–463).10 None of these changes was present in control chromosomes.
Three novel frameshift mutations were also identified, including two one base pair deletions and one four base pair deletion, all occurring in exon 1. In two of them (p.Lys3fsX93 and p.Gly189fsX21), mRNA would be predicted to succumb to nonsense-mediated decay; if however they were translated, the encoded proteins would be severely truncated and predicted to be non-functional since they would lack all transmembrane helices and the pore region. The p.Phe400fsX53 mutation shifts the protein frame before the fifth transmembrane domain and the pore. These results are summarised in table 2.
This report presents novel SD-OCT data in a cohort of patients with mutations in KCNV2 resulting in ‘cone dystrophy with supernormal rod ERG’, and describes five novel mutations. Mutations in genes encoding potassium channels cause a number of diverse phenotypes both in animal models and in man, which include long QT syndrome, epilepsy and snowflake vitreoretinal degeneration.12‐14 Potassium channelopathies are good candidates for novel therapeutic approaches including the development of drugs targeting the ion channel.1
SD-OCT enables high resolution, cross-sectional visualisation of retinal structure, and allows assessment of the structural integrity of the photoreceptor layer, an important parameter for the success of gene therapy or pharmacological modulation strategies.15 16 Thinning and non-specific changes in the foveal outer retinal layers were present in all patients. An unusual optical gap similar to that described in cases with achromatopsia8 due to mutations in PDE6C17 or CNGA3,18 occult maculopathy19 and less commonly in Stargardt disease,20 was observed in the SD-OCTs of a sibling pair (cases 6 and 7).
In this cross-sectional study, more severe morphological changes in SD-OCT with increasing age cannot be excluded, suggesting that there might be progressive loss of foveal photoreceptors; this is consistent with observations made on the basis of autofluorescence imaging.6 However, it is noted that the two youngest patients in our cohort (cases 1 and 2) presented with a relatively severe OCT phenotype and longitudinal studies are needed to more accurately determine the natural history of the disorder.
Fundoscopic and gross OCT abnormalities appear to be confined to the central retina. This is despite the fact that KCNV2 is expressed in both rod and cone photoreceptors and the ERG changes indicate widespread retinal dysfunction. The severity of peripheral retinal dysfunction does not correlate with age and serial recordings, described in a few cases, have shown mild or no deterioration.6 Colour vision testing has shown relative preservation of S-cone function.5 21 These findings together with the OCT changes suggest that foveal cones are particularly susceptible to the deleterious effects of mutant KCNV2, or that KCNV2 is more highly expressed in foveal cones. Future studies with cellular-resolution retinal imaging will more accurately map cone abnormalities in the foveal and parafoveal area and provide further insight.22
It has been previously highlighted that the term ‘cone dystrophy with supernormal rod ERG’ is misleading in the context of this disorder and often a misnomer.6 Dark-adapted ERG amplitudes are not usually greater than normal and it is the highly abnormal intensity response function and the shape of the dark-adapted bright flash ERG that are the findings specific for the condition, together with generalised cone dysfunction (figure 2). Such findings have not been described in any other disorder. Mutations in KCNV2 were detected in all study subjects, in agreement with previous results tightly linking the phenotype of ‘cone dystrophy with supernormal rod ERG’ with mutated Kv8.2.21 We suggest that the term ‘KCNV2 retinopathy’ should be used and promoted rather than ‘cone dystrophy with supernormal rod ERG’.
Kv8.2 (KCNV2) subunits are not functional in isolation and do not form homomeric potassium channels. Instead, they coassemble with Kv2.1 to constitute functional heteromers.2 10 Kv2.1 (KCNB1) subunits are expressed in neurons and neuroendocrine cells and can form both homo and heteromeric channels.23 Mutations in KCNV2 can lead to either completely absent or dysfunctional Kv8.2/Kv2.1 channels. When KCNV2 mRNA is not translated, Kv2.1 homomeric channels are formed.2 24 This is predicted to be the case in patients with biallelic mutations that trigger nonsense mediated mRNA decay. Conversely, mutations affecting the pore-forming loop like p.Gly461Arg are expected to result in present but non-functional Kv8.2/Kv2.1 heteromeres.2 24 Patients 2, 6, 7 and 8 carry alleles in the first category, while patient 12 is homozygous for a mutation in the pore. No significant difference in severity of clinical, electrophysiological (figure 1) or OCT phenotype emerges when comparing these groups with each other or with the rest of the patients.
KCNV2 retinopathy is a recessive early onset retinal dystrophy which has a characteristic electrophysiological phenotype. Foveal structural abnormalities are demonstrated in SD-OCT even in the early stages of disease. Undetectable pattern ERG recordings are a consistent feature and suggest that there is more widespread macular dysfunction, affecting morphologically intact photoreceptors. Future therapeutic approaches such as gene replacement or pharmacological therapy may restore function to these cells or slow the degenerative process.
Funding The British Retinitis Pigmentosa Society, Fight for Sight, Moorfields Eye Hospital Special Trustees and the National Institute for Health Research UK provided the Biomedical Research Centre for Ophthalmology based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, and The Foundation Fighting Blindness (USA) with funding for this study.
Competing interests None.
Ethics approval This study was conducted with the approval of the Moorfields and Whittington Hospitals Research Ethics Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.